HomeNDC LookupRxCUI directory › RxCUI 1012706

1.8 ML prilocaine hydrochloride 40 MG/ML Cartridge [Citanest] — RxCUI 1012706

RxNorm drug concept · Semantic branded drug
RxCUI 1012706 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1012706
Official name1.8 ML prilocaine hydrochloride 40 MG/ML Cartridge [Citanest]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as1.8 ML Citanest 40 MG/ML Cartridge; Citanest Plain 4 % in 1.8 ML Cartridge
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How 1.8 ML prilocaine hydrochloride 40 MG/ML Cartrid... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 1.8 ML prilocaine hydrochloride 40 MG/ML Cartridge [Citanest] RxCUI 1012706

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Prilocaine 8686
    • Prilocaine hydrochloride 2557
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Citanest 151518
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Prilocaine Cartridge 1734943
    • Prilocaine hydrochloride Cartridge 2647037
    • Prilocaine Injectable Product 1161714
    • Prilocaine hydrochloride Injectable Product 2662409
    • Prilocaine Cartridge [Citanest] 1734945
    • Prilocaine hydrochloride Cartridge [Citanest] 2657169
    • Citanest Injectable Product 1170915
    • Cartridge 1649572
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 1.8 ML prilocaine hydrochloride 40 MG/ML Cartridge SCD · 1595048
  • Prilocaine hydrochloride 40 MG/ML SCDC · 1012699
  • Prilocaine Cartridge SCDF · 1734943
  • Prilocaine hydrochloride Cartridge SCDFP · 2647037
  • Prilocaine Injectable Product SCDG · 1161714
  • Prilocaine hydrochloride Injectable Product SCDGP · 2662409

Brand-Name Concepts

  • Prilocaine hydrochloride 40 MG/ML [Citanest] SBDC · 1012702
  • Prilocaine Cartridge [Citanest] SBDF · 1734945
  • Prilocaine hydrochloride Cartridge [Citanest] SBDFP · 2657169
  • Citanest Injectable Product SBDG · 1170915
  • Citanest BN · 151518

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1012706 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
66312-0630-14 50 CARTRIDGE in 1 CARTON (66312-630-14) / 1.8 mL in 1 CARTR... Citanest Plain Dentsply Pharmaceutical Inc. 1965-11-18
Observed labelers: Dentsply Pharmaceutical Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.